This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paliwal, S. Articles by Grossman, S. R. Search for Related Content PubMed PubMed Citation Articles by Paliwal, S. Articles by Grossman, S. R.

The Alternative Reading Frame Tumor Suppressor Antagonizes Hypoxia-Induced Cancer Cell Migration via Interaction with the COOH-Terminal Binding Protein Corepressor

Departments of ¹ Cancer Biology and ² Medicine; ³ Program in Gene Function and Expression; ⁴ Gastrointestinal Cancer Program, University of Massachusetts Medical School and UMass Memorial Cancer Center, Worcester, Massachusetts

Requests for reprints: Steven R. Grossman, Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605. Phone: 508-856-6423; Fax: 508-856-1699; E-mail: steven.grossman{at}umassmed.edu.

The alternative reading frame (ARF) tumor suppressor exerts both p53-dependent and p53-independent activities critical to the prevention of cancer in mice and humans. Recent evidence from mouse models suggests that when p53 is absent, further loss of ARF can widen the tumor spectrum, and potentiate invasion and metastasis. A major target of the p53-independent activity of ARF is the COOH-terminal binding protein (CtBP) family of metabolically regulated transcriptional corepressors, which are degraded upon acute exposure to the ARF protein. CtBPs are activated under conditions of metabolic stress, such as hypoxia, to repress epithelial and proapoptotic genes, and can mediate hypoxia-induced migration of cancer cells. The possibility that ARF could suppress tumor cell migration as part of its p53-independent activities was thus explored. Small-interfering RNA (siRNA)–mediated knockdown of ARF in human lung carcinoma cells led to increased cell migration, especially during hypoxia, and this effect was blocked by concomitant treatment with CtBP2 siRNA. Introduction of ARF into p53 and ARF-null human colon cancer cells inhibited hypoxia-induced migration. Furthermore, overexpression of CtBP2 in ARF-expressing cells enhanced cell migration, and an ARF mutant defective in CtBP-family binding was impaired in its ability to inhibit cell migration induced by CtBP2. ARF depletion or CtBP2 overexpression was associated with decreased PTEN expression and activation of the phosphatidylinositol 3-kinase pathway, and a phosphatidylinositol 3-kinase inhibitor blocked CtBP2-mediated cell migration. Thus, ARF can suppress cell migration by antagonizing CtBP2 and the phosphatidylinositol 3-kinase pathway, and these data may explain the increased aggressiveness of ARF-null tumors in mouse models. [Cancer Res 2007;67(19):9322–9]

This article has been cited by other articles:

				J. A. Watson, C. J. Watson, A.-M. McCrohan, K. Woodfine, M. Tosetto, J. McDaid, E. Gallagher, D. Betts, J. Baugh, J. O'Sullivan, et al. Generation of an epigenetic signature by chronic hypoxia in prostate cells Hum. Mol. Genet., October 1, 2009; 18(19): 3594 - 3604. [Abstract] [Full Text] [PDF]

				G. Chinnadurai The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors Cancer Res., February 1, 2009; 69(3): 731 - 734. [Abstract] [Full Text] [PDF]

				Y.-W. Chen, S. Paliwal, K. Draheim, S. R. Grossman, and B. C. Lewis p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein Cancer Res., January 15, 2008; 68(2): 476 - 482. [Abstract] [Full Text] [PDF]